Clinical trial Recruiting at 10 sites Interventional Ages 40 and up

Preventing colon anastomotic leaks by stenting the superior mesenteric artery

Official title: Anastomotic Leakage Prevention by Endovascular Stenting of the Superior Mesenteric Artery

Run by Medisch Spectrum Twente · NCT07486570 · Data updated 2026-11-12

This trial tests whether placing a stent in the superior mesenteric artery before elective colon surgery can reduce anastomotic leaks in patients over 40 with an asymptomatic >50% SMA stenosis.

More Colorectal Surgery trials

Quick facts

Study typeInterventional
Ages40 Years and up
SexAll
Enrollment360 (estimated)
SponsorMedisch Spectrum Twente
Academic / other
Locations18 sites (Emmen, Drenthe and 17 other locations)
StatusRecruiting
StartedFebruary 1, 2026
Main results expectedFebruary 1, 2028
Study endsJanuary 1, 2029
Registry record updatedJuly 27, 2026
Trial IDNCT07486570 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults >40 years scheduled for elective colon resection above the recto‑sigmoid junction with a primary anastomosis and an asymptomatic >50% atherosclerotic stenosis at the SMA origin.

Probably not a fit

Patients with symptomatic mesenteric ischemia, a >50% celiac artery stenosis, those undergoing extensive multiorgan or T4b/T4c resections, or whose leak risk is driven by non-perfusion factors are unlikely to gain benefit from preventive SMA stenting.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study offers preoperative percutaneous transluminal angioplasty with covered stent placement of the superior mesenteric artery for patients who have an asymptomatic >50% origin stenosis and are scheduled for elective colon resection with a primary anastomosis. Enrolled patients receive the endovascular procedure and mono antiplatelet therapy, then undergo the planned colectomy; outcomes include rate and severity of anastomotic leakage, delayed leaks, mesenteric artery calcification score, surgical complications, readmissions, and quality of life. It is a multicenter effort at hospitals in the Netherlands and enrolls adults over 40 without symptoms of chronic or acute mesenteric ischemia. The trial aims to determine whether preventive SMA revascularization improves perfusion-related surgical outcomes compared with expected baseline rates.

Why it matters

Potential benefit: If successful, preventive SMA stenting could substantially reduce anastomotic leakage after colon surgery, cutting reoperations and improving long-term survival and quality of life.

How similar studies have gone: Retrospective multicenter case-control data linked >50% SMA stenosis to a six-fold higher leak risk and SMA stenting is established for mesenteric ischemia, but preventive stenting in asymptomatic colorectal surgery patients has not been prospectively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \>40 years.
* Patient scheduled for elective colon resection above the recto-sigmoid junction with a primary anastomosis (side-to-side, side-to-end, or end-to-end).
* Presence of an asymptomatic \>50% atherosclerotic origin stenosis of the superior mesenteric artery (SMA)

Exclusion Criteria:

* All patients with symptomatic chronic or acute mesenteric ischemia (i.e., mesenteric artery stenosis in combination with symptoms as postprandial abdominal pain, fear of eating, altered eating patterns, weight loss, diarrhoea, nausea, or exercise-induced abdominal pain).
* Presence of a \>50% stenosis of the celiac artery, regardless of the underlying pathology (i.e., intra-articular atherosclerosis, intra articular thrombus or external compression by the median accurate ligament).
* Simultaneous performed during the colon resection: a substantial abdominal organ resection, or T4b/T4c colon tumour resection, or a second colon anastomosis or a diverting stoma
* History of mesenteric revascularization, including endovascular stenting, thrombectomy, or bypass surgery involving any of the mesenteric arteries
* Patients with a history of heparin induced thrombocytopenia-type 2 due to contraindication for VBX Stent Graft.
* Patients with a contra-indication for mono antiplatelet therapy with Ascal due to comorbidities, allergy or intolerance.
* Pregnancy

Where it's running

  • Gelre ziekenhuis
    Apeldoorn, Gelderland, Netherlands
    Recruiting
  • Zuyderland
    Heerlen, Limburg, Netherlands
    Recruiting
  • Maastricht Universitair Medisch Centrum (MUMC+)
    Maastricht, Limburg, Netherlands
    Recruiting
  • Jeroen Bosch Ziekenhuis
    's-Hertogenbosch, North Brabant, Netherlands
    Recruiting
  • Noordwest Ziekenhuisgroep
    Alkmaar, North Holland, Netherlands
    Recruiting
  • Ziekenhuisgroep Twente
    Almelo, Overijsel, Netherlands
    Recruiting
Show 12 more locations
  • Medisch Spectrum Twente
    Enschede, Overijsel, Netherlands
    Recruiting
  • Nij Smellinghe
    Drachten, Provincie Friesland, Netherlands
    Recruiting
  • Franciscus
    Rotterdam, South Holland, Netherlands
    Recruiting
  • Maasstad ziekenhuis
    Rotterdam, South Holland, Netherlands
    Recruiting
  • Treant
    Emmen, Drenthe, Netherlands
    Not yet recruiting
  • Meander
    Amersfoort, Gelderland, Netherlands
    Not yet recruiting
  • Spaarne Gasthuis
    Haarlem, North Holland, Netherlands
    Not yet recruiting
  • Martini Ziekenhuis
    Groningen, Provincie Groningen, Netherlands
    Not yet recruiting
  • Universitair Medisch Centrum Groningen
    Groningen, Provincie Groningen, Netherlands
    Not yet recruiting
  • Haaglanden Medisch Centrum
    The Hague, South Holland, Netherlands
    Not yet recruiting
  • Diakonessenhuis
    Utrecht, Utrecht, Netherlands
    Not yet recruiting
  • Albert Schweitzer ziekenhuis
    Dordrecht, Zuid, Netherlands
    Not yet recruiting

Study contacts

  • Principal investigator: Bob H. Geelkerken, Prof. dr. — Medisch Spectrum Twente
  • Study coordinator: Koen J. Vree Egberts, MD, PhD Candicate
  • Email: koen.vreeegberts@mst.nl
  • Phone: +31 6 15247413

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.